AMIX Autonomix Medical, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1617867 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY29.4%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-176.0%
ROA-146.1%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets15.3%
Debt / equity0.00x
Current ratio6.52x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.02x
Accruals ratio2.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $0 |
| R&D expense | $7.14M | $4.72M |
| SG&A expense | $9.89M | $6.86M |
| Operating income | -$17.03M | -$11.59M |
| Interest expense | $0 | $176,000 |
| Pretax income | -$16.71M | -$11.41M |
| Income tax | $0 | $0 |
| Net income | -$16.71M | -$11.41M |
| EBITDA | -$17.02M | -$11.40M |
| EPS (basic) | -2.32 | -6.46 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $7.00M | $9.14M |
| Current assets | $7.58M | $9.61M |
| PP&E, net | $19,000 | $21,000 |
| Total assets | $7.60M | $9.81M |
| Current liabilities | $1.71M | $1.71M |
| Total liabilities | $1.71M | $1.71M |
| Shareholders' equity | $5.89M | $8.10M |
| Shares outstanding | 542,312 | 2.50M |
| Cash flow statement | ||
| Operating cash flow | -$12.28M | -$8.26M |
| Capital expenditure | $10,000 | $14,000 |
| Free cash flow | -$12.29M | -$8.27M |
| Investing cash flow | -$10,000 | -$14,000 |
| Financing cash flow | $10.16M | $8.80M |
| Depreciation & amortization | $12,000 | $183,000 |
| Stock-based compensation | $529,000 | $1.63M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.